He has extensive clinical and research experience in examining the impact of lifestyle interventions in reversing frailty in older adults with obesity. His clinical and translational laboratories involve hormonal, nutritional, and behavioral/lifestyle interventions to retard or reverse the metabolic and physical complications of aging, including sarcopenic obesity and type 2 diabetes. He is dedicated to research designed to inform practice guidelines with regard to optimal treatment strategies for obesity in older adults.